200-day SMA
$1.77
+$0.00+0.07%
27 November 2024
50-day SMA
$1.99
+$0.03+1.59%
27 November 2024
Summary:
Inhibikase Therapeutics 200-day simple moving average is currently $1.77, with a rise of +$0.00 (+0.07%) during the most recent trading day. Over the past year, it has dropped by -$1.02 (-36.57%). IKT 200-day SMA is now -97.02% below its all-time high of $59.40.IKT Moving Average Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IKT Moving Average Performance
| PeriodPeriod | 200-day SMA200-day SMA | 50-day SMA50-day SMA | PricePrice | TTM Dividend yieldTTM Dividend yield |
|---|---|---|---|---|
| todaytoday | +0.1% | +1.6% | +11.6% | - |
| 1 m1 month | +0.5% | +36.6% | +7.3% | - |
| 3 m3 months | +4.7% | +43.4% | +85.7% | - |
| 6 m6 months | +4.0% | +6.2% | +36.8% | - |
| ytdytd | -27.3% | +90.7% | +109.7% | - |
| 1 y1 year | -36.6% | +94.1% | +198.8% | - |
| 5 y5 years | - | - | - | - |
IKT Moving Average High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | $1.80 | -1.7% | $1.76 | +0.5% |
| 3 m | 3 months | $1.80 | -1.7% | $1.69 | +4.7% |
| 6 m | 6 months | $1.80 | -1.7% | $1.62 | +9.0% |
| 1 y | 1 year | $2.79 | -36.6% | $1.62 | +9.0% |
| 3 y | 3 years | $22.30 | -92.1% | $1.62 | +9.0% |
| 5 y | 5 years | $59.40 | -97.0% | $1.62 | +9.0% |
| alltime | all time | $59.40 | -97.0% | $1.62 | +9.0% |
Inhibikase Therapeutics Moving Average History
| Date | Value |
|---|---|
| 2024 | $1.77(-27.2%) |
| 2023 | $2.43(-53.5%) |
| Date | Value |
|---|---|
| 2022 | $5.23(-71.9%) |
| 2021 | $18.64(-63.2%) |
| 2020 | $50.70 |
FAQ
- What is Inhibikase Therapeutics 200-day simple moving average?
- What is the all time high 200-day SMA for Inhibikase Therapeutics?
- What is IKT 200-day simple moving average year-to-date change?
- What is Inhibikase Therapeutics 200-day SMA year-on-year change?
What is Inhibikase Therapeutics 200-day simple moving average?
The current 200-day SMA of IKT is $1.77
What is the all time high 200-day SMA for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high 200-day simple moving average is $59.40
What is IKT 200-day simple moving average year-to-date change?
Inhibikase Therapeutics 200-day simple moving average has changed by -$0.66 (-27.25%) since the beginning of the year
What is Inhibikase Therapeutics 200-day SMA year-on-year change?
Over the past year, IKT 200-day simple moving average has changed by -$1.02 (-36.57%)